Aims and scope
As a highly respected journal with an international readership, Immunohematology, Journal of Blood Group Serology and Molecular Genetics is published quarterly (March, June, September, and December) by The American National Red Cross.The journal is subscription based and peer reviewed and brings together research and clinical practice from well-known experts in the field of blood group serology and molecular immunogenetics.
Aim and Scope
Immunohematology, Journal of Blood Group Serology and Molecular Genetics publishes case reports, original scientific reports, conference reports, book reviews, editorial commentaries, and review articles covering the spectrum of clinical and laboratory practice and research in the field of laboratory medicine. The journal welcomes manuscripts on red cell, white cell, and platelet serology as well as original scientific investigations of new blood group alleles, molecular testing platforms, and new methods for use in the blood bank. Immunohematology cases that illustrate a sound investigative approach with clinical correlation, reflecting appropriate collaboration to sharpen problem-solving skills can be submitted as an educational forum.
Open Access
One article per published issue is available in open access format for all readers. Identification of this article is noted in Newest Articles section.
Peer Review Process
Manuscripts submitted for publication in Immunohematology, Journal of Blood Group Serology and Molecular Genetics are peer reviewed by selected experts in the medical and technical field of transfusion medicine and/or immunohematology. Each peer reviewer assesses the manuscript for the novelty of the information, the quality and completeness of the provided scientific and clinical data, the quality and appropriateness of the tables and figures, the overall clarity of presentation of the information, and the interest of this topic to the readers of this journal. In addition, each reviewer determines if additional statistical review is needed and if the references are current and appropriate.
Peer reviewers provide a final assessment to accept or reject the manuscript outright, or revise the manuscript. If revision is determined, the peer reviewer provides specific comments to improve the quality of the manuscript. The reviewers’ comments are compiled and reviewed by the assigned associate editor who provides additional comments, if appropriate. All comments are then sent to the authors for reply and revision, if applicable.
The authors’ reply and revised manuscript are reviewed by the assigned associate editor and acceptance/rejection of the manuscript is determined.
Confidentiality of all peer reviewers is respected.
Rejection rate: 54%
Subscription Rates
Annual Subscription Rates:
Single article: $35—send email request to immuno@redcross.org
Individual Online Only: $75
Individual US Online and Print: $150
Institution Online Only: $350
Institution US Online and Print: $600
Back issues---printed copies--$15/copy—send email request to immuno@redcross.org
ABOUT SOCIETY
With a focus on better patient outcomes through shared expertise and designed for physicians and laboratory professionals in the areas of blood banking and transfusion medicine, SUCCESS® is a comprehensive suite of educational resources comprised of online instruction, industry publications, and learning events. In support of SUCCESS®, the American National Red Cross publishes Immunohematology, Journal of Blood Group Serology and Molecular Genetics on a quarterly basis with a focus on original research, invited reviews, case reports, and new allele publications.
Announcement
ARC SBB Program Flyer 2024-2025
Advertisements
